Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
Cascinu S, Graziano F, Ferraù F, Catalano V, Massacesi C, Santini D, Silva RR, Barni S, Zaniboni A, Battelli N, Siena S, Giordani P, Mari D, Baldelli AM, Antognoli S, Maisano R, Priolo D, Pessi MA, Tonini G, Rota S, Labianca R.
Cascinu S, et al. Among authors: siena s.
Ann Oncol. 2002 May;13(5):716-20. doi: 10.1093/annonc/mdf091.
Ann Oncol. 2002.
PMID: 12075739
Free article.
Clinical Trial.